Business Description
Zenith Drugs Ltd
ISIN : INE0QWN01013
Total Employee Number:
182Compare
Compare
Traded in other countries / regions
ZENITHDRUG.India IPO Date
2024-02-27Description
Zenith Drugs Ltd is a pharmaceutical manufacturing and trading company. It offers a wide range of formulations in various forms such as ORS Powder, Liquid Orals, Ointments, Liquid Externals, Creams, Gels, Capsules, and Tablets. It is also into Generic Medicines.
Financial Strength
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 0.01 | |||||
Equity-to-Asset | 0.39 | |||||
Debt-to-Equity | 0.75 | |||||
Debt-to-EBITDA | 3.23 | |||||
Interest Coverage | 1.09 | |||||
Piotroski F-Score | 4/9 | |||||
Altman Z-Score | 1.8 | |||||
Beneish M-Score | -2.04 | |||||
WACC vs ROIC | ||||||
Growth Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 14.4 | |||||
3-Year EBITDA Growth Rate | 23.2 | |||||
3-Year EPS without NRI Growth Rate | -5 | |||||
3-Year FCF Growth Rate | 22.1 | |||||
3-Year Book Growth Rate | 60.6 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 44.42 | |||||
9-Day RSI | 53.87 | |||||
14-Day RSI | 56.55 | |||||
3-1 Month Momentum % | -8.57 | |||||
6-1 Month Momentum % | -18.61 | |||||
12-1 Month Momentum % | -42.11 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 1.37 | |||||
Quick Ratio | 0.92 | |||||
Days Inventory | 119.67 | |||||
Days Sales Outstanding | 137.54 | |||||
Days Payable | 131.37 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Shareholder Yield % | -5.48 |
Profitability Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 28.42 | |||||
Operating Margin % | 3.57 | |||||
Net Margin % | 2.3 | |||||
EBITDA Margin % | 9.96 | |||||
FCF Margin % | -2.85 | |||||
OCF Margin % | 5.18 | |||||
ROE % | 5.52 | |||||
ROA % | 2.3 | |||||
ROIC % | 3.56 | |||||
3-Year ROIIC % | -2.19 | |||||
ROC (Joel Greenblatt) % | 10.61 | |||||
ROCE % | 12.67 | |||||
Years of Profitability over Past 10-Year | 6 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PE Ratio | 21.78 | |||||
PE Ratio without NRI | 20.66 | |||||
Price-to-Owner-Earnings | 323.77 | |||||
PEG Ratio | 0.92 | |||||
PS Ratio | 0.5 | |||||
PB Ratio | 1.17 | |||||
Price-to-Tangible-Book | 1.24 | |||||
Price-to-Operating-Cash-Flow | 9.61 | |||||
EV-to-EBIT | 12.79 | |||||
EV-to-EBITDA | 8.25 | |||||
EV-to-Revenue | 0.83 | |||||
EV-to-FCF | -29.67 | |||||
Price-to-Peter-Lynch-Fair-Value | 0.93 | |||||
Price-to-Graham-Number | 1.07 | |||||
| Price-to-Net-Current-Asset-Value | 5.8 | |||||
Earnings Yield (Greenblatt) % | 7.82 | |||||
FCF Yield % | -5.68 | |||||
Forward Rate of Return (Yacktman) % | 6.11 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Zenith Drugs Ltd Executives
DetailsGF Valueâ„¢
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil ₹) | 1,712.198 | ||
| EPS (TTM) (₹) | 2.3 | ||
| Beta | - | ||
| 3-Year Sharpe Ratio | - | ||
| 3-Year Sortino Ratio | - | ||
| Volatility % | 45.5 | ||
| 14-Day RSI | 56.55 | ||
| 14-Day ATR (₹) | 2.429113 | ||
| 20-Day SMA (₹) | 48.1925 | ||
| 12-1 Month Momentum % | -42.11 | ||
| 52-Week Range (₹) | 33.3 - 76 | ||
| Shares Outstanding (Mil) | 17.15 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 4 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Zenith Drugs Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Zenith Drugs Ltd Stock Events
| Event | Date | Price (₹) | ||
|---|---|---|---|---|
| INR 0.500000 Cash Dividend | 2024-09-17 | 139.50 (+2.61%) |
Show
Entries
Zenith Drugs Ltd Frequently Asked Questions
What is Zenith Drugs Ltd(NSE:ZENITHDRUG)'s stock price today?
The current price of NSE:ZENITHDRUG is ₹50.10. The 52 week high of NSE:ZENITHDRUG is ₹76.00 and 52 week low is ₹33.30.
When is next earnings date of Zenith Drugs Ltd(NSE:ZENITHDRUG)?
The next earnings date of Zenith Drugs Ltd(NSE:ZENITHDRUG) is .
Does Zenith Drugs Ltd(NSE:ZENITHDRUG) pay dividends? If so, how much?
Zenith Drugs Ltd(NSE:ZENITHDRUG) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Articles on Zenith Drugs Ltd
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers